Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-9-20
pubmed:abstractText
The marine toxin gambierol, a polyether ladder toxin derived from the marine dinoflagellate Gambierdiscus toxicus, was evaluated for interaction with voltage-gated sodium channels (VGSCs) in cerebellar granule neuron (CGN) cultures. At concentrations ranging from 10 nM to 10 microM, gambierol alone had no effect on the intracellular Ca2+ concentration [Ca2+]i of exposed CGN cultures. Furthermore, there was no evidence of neurotoxicity in CGN cultures exposed for 2 h to gambierol (1 nM-10 microM). However, gambierol was a potent inhibitor (IC50 = 189 nM) of the elevation of [Ca2+]i that accompanies exposure of CGN cultures to the VGSC activator brevetoxin-2 (PbTx-2). To further explore the potential interaction of gambierol with VGSCs, the influence of gambierol on PbTx-2-induced neurotoxicity was assessed. Gambierol reduced the PbTx-2-induced efflux of lactate dehydrogenase in exposed CGN cultures in a concentration-dependent manner (IC50 = 471 nM). It is noteworthy that the potencies of gambierol as an inhibitor of both PbTx-2-induced Ca2+ influx and cytotoxicity were coincident. Finally, the inhibitory effects of gambierol on PbTx-2-induced elevation of [Ca2+]i were compared with those of brevenal, a natural inhibitor of the toxic effects of brevetoxin isolated from cultures of Karina brevis. Like gambierol, brevenal inhibited PbTx-2-induced elevation of [Ca2+]i in a concentration-dependent manner (IC50 = 108.6 nM). These results provide evidence for gambierol acting as a functional antagonist of neurotoxin site 5 on neuronal VGSCs.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-10737600, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-10936626, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-11086218, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-11895121, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-12169106, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-12182604, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-12657316, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-12852956, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-1324537, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-14505411, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-14757203, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-15233378, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-15372697, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-15447946, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-15679307, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-15689421, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-15808523, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-15866774, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-16307526, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-16791001, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-16868017, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-2426567, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-2884353, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-7296283, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-9029269, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-9383457, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-9454792, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-9756332, http://linkedlifedata.com/resource/pubmed/commentcorrection/17609421-9920485
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0022-3565
pubmed:author
pubmed:issnType
Print
pubmed:volume
323
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
174-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17609421-Animals, pubmed-meshheading:17609421-Animals, Newborn, pubmed-meshheading:17609421-Binding Sites, pubmed-meshheading:17609421-Calcium, pubmed-meshheading:17609421-Cell Survival, pubmed-meshheading:17609421-Cells, Cultured, pubmed-meshheading:17609421-Cerebellum, pubmed-meshheading:17609421-Ciguatoxins, pubmed-meshheading:17609421-Ethers, Cyclic, pubmed-meshheading:17609421-Marine Toxins, pubmed-meshheading:17609421-Molecular Structure, pubmed-meshheading:17609421-Neurons, pubmed-meshheading:17609421-Oxocins, pubmed-meshheading:17609421-Polycyclic Compounds, pubmed-meshheading:17609421-Rats, pubmed-meshheading:17609421-Rats, Sprague-Dawley, pubmed-meshheading:17609421-Sodium Channel Blockers, pubmed-meshheading:17609421-Sodium Channels, pubmed-meshheading:17609421-Synaptosomes
pubmed:year
2007
pubmed:articleTitle
Gambierol acts as a functional antagonist of neurotoxin site 5 on voltage-gated sodium channels in cerebellar granule neurons.
pubmed:affiliation
Department of Biology, Xavier University of Louisiana, New Orleans, Louisiana, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural